Anebulo Pharmaceuticals Inc (ANEB)
1.46
-0.04
(-2.67%)
USD |
NASDAQ |
Nov 22, 16:00
1.59
+0.13
(+8.90%)
After-Hours: 20:00
Anebulo Pharmaceuticals Cash from Operations (Quarterly): -1.69M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -1.69M |
| June 30, 2024 | -2.053M |
| March 31, 2024 | -1.497M |
| December 31, 2023 | -1.814M |
| September 30, 2023 | -2.727M |
| June 30, 2023 | -2.849M |
| March 31, 2023 | -2.190M |
| December 31, 2022 | -2.609M |
| September 30, 2022 | -2.034M |
| Date | Value |
|---|---|
| June 30, 2022 | -1.999M |
| March 31, 2022 | -1.461M |
| December 31, 2021 | -1.199M |
| September 30, 2021 | -0.7779M |
| June 30, 2021 | -3.497M |
| March 31, 2021 | -0.8289M |
| December 31, 2020 | -0.41M |
| September 30, 2020 | -0.135M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-3.497M
Minimum
Jun 2021
-0.135M
Maximum
Sep 2020
-1.751M
Average
-1.814M
Median
Dec 2023
Cash from Operations (Quarterly) Benchmarks
| Revance Therapeutics Inc | -41.09M |
| NovaBay Pharmaceuticals Inc | -2.061M |
| Palatin Technologies Inc | -7.016M |
| iBio Inc | -3.715M |
| Theriva Biologics Inc | -3.913M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | -7.054M |
| Free Cash Flow Per Share (Quarterly) | -0.0652 |
| Free Cash Flow Yield | -18.66% |